Jaqueline Diniz Pinho
Research Subjects
Jaqueline Diniz Pinho has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Machado Alencar Junior
Department of Medical Oncology, Hospital Universitário da Universidade Federal do Maranhão, Hospital São Domingos, São Luís, BRA
1 shared publication - Antonio Teixeira-Júnior
Postgraduate Program in Adult Health (PPGSAD), Federal University of Maranhão, UFMA, São Luís, MA 65080-805, Brazil
1 shared publication - Ciro Bezerra Vieira
University Hospital of Federal University of Maranhão (UFMA), Barão de Itapari Street, Centro, São Luís, Brazil
1 shared publication - Emilly Caroline dos Santos Moraes1 shared publication
- Fernando Augusto Soares
Department of Pathology, A.C. Camargo Cancer Center, São Paulo, Brazil
1 shared publication - Francisco Sérgio Moura Silva Do Nascimento
University Hospital of Federal University of Maranhão (UFMA), Barão de Itapari Street, Centro, São Luís, Brazil
1 shared publication
Latest Publications
- Open Access
- 18 September 2020
- Published by Springer Nature in BMC Research Notes
- Vol. 13 (1) , 1-3
A cohort study among 402 patients with penile cancer in Maranhão, Northeast Brazil with the highest worldwide incidence
Objective: Maranhão State—Northeast Brazil–has the world’s highest incidence of penile cancer. This study describes the epidemiological, histopathological and clinical profile of patients stricken across that Brazilian state. The study is aimed at providing new data on neoplasia. Data description: 402 men stricken with penile cancer were studied from January 2004 to December 2018. A retrospective stage was developed with collection of physical and electronic records. A prospective stage was performed with collection of clinical and epidemiological information through a questionnaire. The surgical material was looked into by a uropathologist, and the lesions were evaluated for macroscopic characteristics and various microscopic parameters. Three articles using this data have already been published.
- 18 September 2020
- Published by Springer Nature in BMC Research Notes
- Vol. 13 (1) , 1-3
Open AccessA cohort study among 402 patients with penile cancer in Maranhão, Northeast Brazil with the highest worldwide incidence
Objective: Maranhão State—Northeast Brazil–has the world’s highest incidence of penile cancer. This study describes the epidemiological, histopathological and clinical profile of patients stricken across that Brazilian state. The study is aimed at providing new data on neoplasia. Data description: 402 men stricken with penile cancer were studied from January 2004 to December 2018. A retrospective stage was developed with collection of physical and electronic records. A prospective stage was performed with collection of clinical and epidemiological information through a questionnaire. The surgical material was looked into by a uropathologist, and the lesions were evaluated for macroscopic characteristics and various microscopic parameters. Three articles using this data have already been published.
- Open Access
- 6 February 2019
- Published by IntechOpen
Molecular and Biotechnological Approaches in the Diagnosis of Leprosy
Leprosy is a worldwide health problem, which needs the development of new and innovative strategies to be controlled. Early diagnosis of leprosy is an important contribution to reducing the incidence of the disease; thus, the development of biotechnology platforms, which include the mapping of antigens with potential to be used in immunodiagnostic and molecular methods for the detection of Mycobacterium leprae, is an important tool to confirm the clinical diagnostic. Molecular biology and biotechnological methods have been used to assist in the diagnosis of this disease, each one with its advantages and drawbacks. Enzyme-linked immunosorbent assay (ELISA) is the used method for leprosy diagnosis, and it allows the detection of infection-related antigens. Alternatively, due to their versatility to perform the same functions as the protein and non-protein natural antigens, mimetic peptides are considered an important tool. On the other hand, lateral flow assay (LFA) and optical and electrochemical biosensors are rapid and portable methods, capable of performing diagnosis in the field without sample preparation. This chapter presents such techniques, their uses in the diagnosis and detection of M. leprae, as well as the potential for the development of new techniques and strategies that can help to control and understand mycobacteriosis.
- 6 February 2019
- Published by IntechOpen
Open AccessMolecular and Biotechnological Approaches in the Diagnosis of Leprosy
Leprosy is a worldwide health problem, which needs the development of new and innovative strategies to be controlled. Early diagnosis of leprosy is an important contribution to reducing the incidence of the disease; thus, the development of biotechnology platforms, which include the mapping of antigens with potential to be used in immunodiagnostic and molecular methods for the detection of Mycobacterium leprae, is an important tool to confirm the clinical diagnostic. Molecular biology and biotechnological methods have been used to assist in the diagnosis of this disease, each one with its advantages and drawbacks. Enzyme-linked immunosorbent assay (ELISA) is the used method for leprosy diagnosis, and it allows the detection of infection-related antigens. Alternatively, due to their versatility to perform the same functions as the protein and non-protein natural antigens, mimetic peptides are considered an important tool. On the other hand, lateral flow assay (LFA) and optical and electrochemical biosensors are rapid and portable methods, capable of performing diagnosis in the field without sample preparation. This chapter presents such techniques, their uses in the diagnosis and detection of M. leprae, as well as the potential for the development of new techniques and strategies that can help to control and understand mycobacteriosis.